TickerTalks
Browse all tickers →
TickerTalks›$PACS
PAPACS

PACS Group, Inc.

$PACS·$7.7B·Medical - Care Facilities·Healthcare
$42.75-3.4%YTD+16.4%1Y+268.2%
Mentions · last 7 days
2026-08-20: 1 posts2026-08-21: 1 posts2026-08-22: 0 posts2026-08-23: 0 posts6-14%
Price updated 1d ago·X counts updated 6d ago
PAPACS
$PACSPACS Group, Inc.
$42.75-3.37%6 posts-14%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $PACS, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersAcceleratingAI verdict · as of 2026-08-29

The move is getting stronger, with heavier trading behind it.

Post-acute healthcare compounder +268% t12m; Murray insider distribution of $13.3M+ is the material counter.

PACS Group is a $7.67B post-acute healthcare services holding (skilled nursing facilities, ancillary services) at $42.75 — +16% YTD, +268% t12m, sitting at 84% of its 52w range and +16% above the 200d.

  • Q2 EPS $0.63 vs $0.54 (+17.3% beat), Q1 $0.50 vs $0.42 (+19%), Q4 2025 $0.43 vs $0.48 (-10.4% miss) — mostly-beat cadence with Q4 the only miss.
  • Q1 revenue $1.42B (+11.2% YoY), Q4 2025 $1.36B (+12.4%) — real double-digit revenue growth.
  • Cash economics: PE 23.8, PS 1.08, ROIC 5.5%, ROE 26.6%, gross margin 19.2%, op-margin 7%, D/E 2.99 (elevated), EV/EBITDA 19.6, FCF yield 4.0%.
  • Analyst path FY26 EPS $2.29 → FY27 $2.49 (+8.7% growth).
  • Insider signal is DECISIVELY DISTRIBUTIONAL: Murray Jason Hulse S-Sales across Aug 19 + 24 totaling $13.3M+ (four transactions totaling 302K shares) — massive insider distribution cluster into the strength.
  • News framing: "Amid Legal Risks, This Company Is Still Rated a Buy" — the SEC/DOJ / Medicare-fraud litigation-risk overhang narrative.
  • Sentiment feed is empty.

Read as a post-acute healthcare compounder with real revenue growth + mostly-beat cadence but material $13.3M+ Murray insider distribution + legal-risk overhang; the debated question is whether Q3 confirms the earnings-growth cadence or whether the material insider distribution flags specific concentration risk we haven't seen yet.

What to watch: Q3 revenue growth, any additional Murray insider transactions, and legal-risk disclosure updates on the Nov 9 print.

On the calendar: 2026-11-09 Q3 earnings

Read the AI verdict + X sentiment for $PACS

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Operates skilled nursing facilities and senior living centers focused on post-acute rehabilitation care across multiple US states.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Care Facilities sits in its cycle right now — and what that implies for $PACS.

Medical - Care Facilities · Healthcare

No material change from last week — hospital systems continue to rely on travel nursing and locum physician staffing to fill permanent workforce gaps that training pipelines cannot replenish at..

What this means for $PACS

Partial — Operates skilled nursing facilities and senior living centers focused on post-acute rehabilitation care across multiple US states; partial earnings exposure to medical - care facilities demand dynamics through its product portfolio.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+17.6%YTD
+21.9%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
23.8How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
5.5%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
7.0%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
4.0%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
1.1Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
26.6%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
19.2%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
3.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 4, 2026$0.63$0.54+17.3%
Q1 2026May 11, 2026$0.50$0.42+19.0%
Q4 2025Feb 26, 2026$0.43$0.48-10.4%
Q3 2025Nov 19, 2025$0.33$0.45-26.7%
Next earningsMon, Nov 9·consensus EPS $0.57

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$1.4B+11.2%16.4%8.5%$0.51$214.5M
Q4 FY25$1.4B+12.4%16.5%7.0%$0.38$-117.7M
Q3 FY25$1.3B+31.0%22.2%6.4%$0.33$106.4M
Q2 FY25$1.3B+33.3%22.0%6.1%$0.33$33.8M

Forward consensus

3-year forecast · up to 3 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$5.8B$5.7B – $5.8B$2.29$2.25 – $2.333
FY27$6.2B$6.1B – $6.3B$2.49$2.48 – $2.503
FY28$6.9B$6.8B – $6.9B$2.73$2.69 – $2.761

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.6×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.84%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-3.2%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+15.6%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 47.8M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.0% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β-0.085-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellAug 21Murray Jason HulseCEO59.2K sh$2.6MSellAug 20Murray Jason HulseCEO91.3K sh$4.0MSellAug 19Murray Jason HulseCEO84.7K sh$3.7MSellAug 18Murray Jason HulseCEO66.8K sh$3.0MSellAug 17Murray Jason HulseCEO84.6K sh$3.7MSellAug 14Conway Patrick HughDirector3.5K sh$155KSellAug 12Joshua JergensenCOO40.0K sh$1.8MSellJul 15Joshua JergensenCOO40.0K sh$1.8MSellJul 15Mark HancockDirector3.3K sh$150KSellJul 14Mark HancockDirector10.3K sh$464K
1–10 of 27
+ 25 other (20 awards · 3 inkinds · 2 gifts) in window

See when $PACS insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KShareholder voteJun 158-K — Item 5.07: Shareholder vote
AI summary

PACS Group, Inc. (PACS) reported annual meeting vote results (Item 5.07) in an 8-K filed June 15, 2026. Body unavailable — excerpt cuts off before specific vote tallies are disclosed.

3New insider — initial holdingsApr 273
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for PACS on 2026-04-27, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

8-KOfficer or director changeApr 278-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
AI summary

PACS disclosed a personnel change (8-K Item 5.02, dated 2026-04-27). An executive departure and a new appointment are both reported. Chief Financial Officer but will continue to serve as Executive Vice Chairman. Personnel changes are generally administrative; materiality depends on seniority and circumstances.

3New insider — initial holdingsMar 53
8-KOfficer or director changeMar 58-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
3New insider — initial holdingsMar 33
3New insider — initial holdingsMar 33
+ 7 other (2 earnings 8-Ks · 2 10-Qs · 2 proxys · 1 13G) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Allegion Redefines Commercial Access Control with the Schlage XE360™ Series featuring RealSync™ Persistent Wi-Fi Technologygurufocus.com·5d agoZacks Industry Outlook CareDx, BrightSpring and PACSzacks.com·5d ago3 Medical Service Stocks Resilient Amid Persistent Workforce Shortagezacks.com·6d agoAmid Legal Risks, This Company Is Still Rated a Buymarketbeat.com·11d agoWall Street Analysts See a 25.73% Upside in PACS Group, Inc. (PACS): Can the Stock Really Move This High?zacks.com·17d ago

More in Medical - Care Facilities

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$AVAH$THC$HCA$STLN$DVA$CON$NUTX$AMN
Voices on X · last 7 days

No standout posts about $PACS on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport